Studies related to Sleep Quality and Cannabis

Cannabinoids For Treatment Of Spasticity And Other Symptoms Related To Multiple Sclerosis (CAMS Study): Multicentre Randomised Placebo-controlled Trial

Effect Increase
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 630
Sex Both Genders
Age Range 45-64, 65+
Body Types Average
Notes for this study:
In persons with multiple sclerosis given either pure THC or cannabis extracts over 15 weeks, supplementation failed to result in any improvements in physician-assessed physical mobility although patient-reported stiffness, pain, spasticity, and spasms (but not shake/tremor) appeared to be improved with supplementation. This led to improvements in sleep quality, although symptoms of fatigue and depression were unaffected.

Full details on all 10 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.